Mutations in BRCA1 and BRCA2, which cause Hereditary Breast and Ovarian Cancer Syndrome (HBOC), account for around 80% of the 5%–10% of breast cancer cases related to rare mutations.1, 2. The gene discussed is BRCA2; the disease is breast cancer.